Pharmaceuticals giant AstraZeneca is betting big on Rockville, Md., with plans to develop a manufacturing site for cancer treatments, the company announced Tuesday. The company will invest $300 ...

AstraZeneca has announced a $2bn investment plan to expand its biomanufacturing presence in the US state of Maryland, aiming to support 2,600 jobs at its Frederick and Gaithersburg sites.

Test tubes are seen in front of a displayed AstraZeneca logo in this illustration (Reuters) -AstraZeneca said on Tuesday it will invest $300 million in a facility in Rockville, Maryland, for discovery ...

New facility in Rockville, Maryland will focus on manufacturing for critical cancer trials and launch of its commercial cell therapy platforms The facility in Rockville, MD is located less than five ...

MONTGOMERY COUNTY, Md. (DC News Now) — AstraZeneca, a major player in the biopharmaceutical industry, said it plans to spend $300 million to expand its operations in Rockville. The expansion, made ...

AstraZeneca to Expand Manufacturing with $2 Billion Commitment Governor Wes Moore announced on November 21, 2025, that AstraZeneca, a global biopharmaceutical company, will invest $2 billion to expand ...

AstraZeneca will invest $300 million to establish a manufacturing facility in Rockville, Maryland. The global science-led biopharmaceutical company plans to use the site to “launch its life-saving ...

Alexandria Real Estate Equities (NYSE:ARE) said on Monday that its long-term tenant, AstraZeneca (NASDAQ:AZN), will invest $300M in a cell manufacturing facility at ARE's Shady Grove mega campus in ...

PASADENA, Calif., Feb. 12, 2024 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the first, preeminent, longest-tenured and pioneering owner, operator and developer of collaborative ...

As President Donald Trump’s tariff policies loom, global pharmaceutical giant AstraZeneca will invest $50 billion to boost its American manufacturing and R&D infrastructure. Chief among the company’s ...

(Reuters) -AstraZeneca said on Tuesday it will invest $300 million in a facility in Rockville, Maryland, for discovery and development of cell therapies. More than 150 jobs will be created at the site ...